Semaglutide
- All
- News
- Web Stories
-
Weight-Loss Injections May Increase Blindness Risk, Study Warns
A recent study in JAMA Ophthalmology links semaglutide medications, used for weight loss and diabetes, to an increased risk of NAION, a rare eye condition causing sudden vision loss.
-
Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.
-
Research Reveals Popular Obesity Treatment That Could Help Fight Cancer
Despite whether or not patients experience weight loss, a well-known anti-obesity medication has been proven to reinstate the functionality of immune cells that fight cancer.
-
Weight-Loss Injections May Increase Blindness Risk, Study Warns
A recent study in JAMA Ophthalmology links semaglutide medications, used for weight loss and diabetes, to an increased risk of NAION, a rare eye condition causing sudden vision loss.
-
Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.
-
Research Reveals Popular Obesity Treatment That Could Help Fight Cancer
Despite whether or not patients experience weight loss, a well-known anti-obesity medication has been proven to reinstate the functionality of immune cells that fight cancer.
